Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 167
  • Home
  • Print this page
  • Email this page
ORIGINAL ARTICLE
Year : 2017  |  Volume : 3  |  Issue : 2  |  Page : 111-115

Computed tomography-guided Tru-cut biopsy of lung mass, as an important diagnostic tool: Histopathological characteristics, age, sex distribution, and risk factors in Misurata Cancer Center, Libya


1 Department of Surgical Oncology, Misurata Cancer Centre, Misurata, Libya
2 Department of Clinical Histopathology, Misurata Cancer Centre, Misurata, Libya
3 Department of Graduate and Postdoctoral Studies, Faculty of Health Sciences, University of Ottawa, Ottawa, Canada

Correspondence Address:
Dr. Mohamed Alhashmi M. Sidoun
Department of Surgical Oncology, Misurata Cancer Center, Misurata
Libya
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ASJO.ASJO_12_17

Rights and Permissions

Background: Lung biopsies may be classified according to the method of access or by the reason for biopsy. Tru-cut biopsy is a simple, relatively safe, rapid, and reliable technique for the diagnosis of lung mass lesions, particularly with the aid of computed tomography (CT) scan. This procedure is commonly used worldwide to detect different kinds of lung tumors, but its usefulness in Libya is not yet studied. Objectives: The aim of this study was to assess the usefulness of Tru-cut biopsy as a diagnostic method in lung tumors and also to determine the incidence of lung cancer in various ages and sex groups and in relation to smoking data. Patients and Methods: Retrospective study was done on 136 patients who underwent CT-guided Tru-cut biopsy from January 2012 to March 2015. The included patients have lung mass lesions suspected to be neoplastic according to chest radiograph and/or CT scan. Results: We found biopsies and histopathology reports of 136 cases. The patients' age was from 20 to 85 years with the peak incidence in the sixth and seventh decades. The benign lesions were 18 (13.23%), and malignant lesions were 118 (86.76%) documented microscopically. The most common tumor was squamous cell carcinoma (25.17%), followed by adenocarcinoma (23.02%) and small cell lung carcinoma (17.26%). Nonspecific inflammation was found in 8.63%. Conclusion: CT-guided Tru-cut biopsy is a simple, safe, and reliable procedure with high diagnostic accuracy for the diagnosis and subtyping of lung cancer. The definitive result of malignancy is a base for correct decision for the patient's treatment after careful clinical correlation with performance state, radiology findings, and complete serological investigations.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed331    
    Printed22    
    Emailed0    
    PDF Downloaded107    
    Comments [Add]    

Recommend this journal